| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22214630.0AEP4219717A3 (en) | 2018-06-13 | 2019-06-12 | Exon skipping oligomers for muscular dystrophy |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684615P | 2018-06-13 | 2018-06-13 | |
| PCT/US2019/036764WO2019241385A2 (en) | 2018-06-13 | 2019-06-12 | Exon skipping oligomers for muscular dystropy |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22214630.0ADivisionEP4219717A3 (en) | 2018-06-13 | 2019-06-12 | Exon skipping oligomers for muscular dystrophy |
| Publication Number | Publication Date |
|---|---|
| EP3806868A2 EP3806868A2 (en) | 2021-04-21 |
| EP3806868A4true EP3806868A4 (en) | 2022-06-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19818767.6AWithdrawnEP3806868A4 (en) | 2018-06-13 | 2019-06-12 | EXON-SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY |
| EP22214630.0APendingEP4219717A3 (en) | 2018-06-13 | 2019-06-12 | Exon skipping oligomers for muscular dystrophy |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22214630.0APendingEP4219717A3 (en) | 2018-06-13 | 2019-06-12 | Exon skipping oligomers for muscular dystrophy |
| Country | Link |
|---|---|
| EP (2) | EP3806868A4 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120289457A1 (en)* | 2011-05-05 | 2012-11-15 | Avi Biopharma, Inc. | Peptide oligonucleotide conjugates |
| WO2017062835A2 (en)* | 2015-10-09 | 2017-04-13 | Sarepta Therapeutics, Inc. | Compositions and methods for treating duchenne muscular dystrophy and related disorders |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH445129A (en) | 1964-04-29 | 1967-10-15 | Nestle Sa | Process for the preparation of high molecular weight inclusion compounds |
| US3459731A (en) | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
| US3453257A (en) | 1967-02-13 | 1969-07-01 | Corn Products Co | Cyclodextrin with cationic properties |
| US3426011A (en) | 1967-02-13 | 1969-02-04 | Corn Products Co | Cyclodextrins with anionic properties |
| US3453259A (en) | 1967-03-22 | 1969-07-01 | Corn Products Co | Cyclodextrin polyol ethers and their oxidation products |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| CA1268404A (en) | 1985-03-15 | 1990-05-01 | Antivirals Inc. | Polynucleotide assay reagent and method |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| KR0166088B1 (en) | 1990-01-23 | 1999-01-15 | . | Cyclodextrin derivatives with increased water solubility and uses thereof |
| US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| EP0654077A4 (en) | 1992-07-17 | 1996-03-13 | Ribozyme Pharm Inc | Method and reagent for treatment of animal diseases. |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5820873A (en) | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| US5753613A (en) | 1994-09-30 | 1998-05-19 | Inex Pharmaceuticals Corporation | Compositions for the introduction of polyanionic materials into cells |
| IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
| US7572582B2 (en) | 1997-09-12 | 2009-08-11 | Exiqon A/S | Oligonucleotide analogues |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| WO1999042091A2 (en) | 1998-02-19 | 1999-08-26 | Massachusetts Institute Of Technology | Use of polycations as endosomolytic agents |
| US6683173B2 (en) | 1998-04-03 | 2004-01-27 | Epoch Biosciences, Inc. | Tm leveling methods |
| US7084125B2 (en) | 1999-03-18 | 2006-08-01 | Exiqon A/S | Xylo-LNA analogues |
| US7053207B2 (en) | 1999-05-04 | 2006-05-30 | Exiqon A/S | L-ribo-LNA analogues |
| US7070807B2 (en) | 1999-12-29 | 2006-07-04 | Mixson A James | Branched histidine copolymers and methods for using same |
| US7163695B2 (en) | 1999-12-29 | 2007-01-16 | Mixson A James | Histidine copolymer and methods for using same |
| EP1446412B1 (en) | 2001-09-04 | 2012-03-07 | Exiqon A/S | Novel lna compositions and uses thereof |
| KR100464261B1 (en) | 2002-01-24 | 2005-01-03 | 주식회사 파나진 | A Novel Monomer For Synthesis of PNA Oligomer And A Process For Producing The Same |
| KR20030084444A (en) | 2002-04-26 | 2003-11-01 | 주식회사 파나진 | A Novel Monomer For Synthesis of PNA Oligomer And A Process For Producing The Same |
| US7569575B2 (en) | 2002-05-08 | 2009-08-04 | Santaris Pharma A/S | Synthesis of locked nucleic acid derivatives |
| AU2003295388A1 (en) | 2002-11-05 | 2004-06-03 | Isis Pharmaceuticals, Inc. | 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| DE602004028930D1 (en) | 2003-04-29 | 2010-10-14 | Avi Biopharma Inc | COMPOSITIONS FOR IMPROVING ANTISENSE EFFECTIVENESS AND TRANSPORT OF NUCLEIC ACID ANALOGUE IN CELLS |
| US7211668B2 (en) | 2003-07-28 | 2007-05-01 | Panagene, Inc. | PNA monomer and precursor |
| FR2874384B1 (en)* | 2004-08-17 | 2010-07-30 | Genethon | ADENO-ASSOCIATED VIRAL VECTOR FOR PRODUCING EXON JUMP IN A GENE ENCODING A PROTEIN WITH DISPENSABLE DOMAINS |
| US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| CA2629323A1 (en) | 2005-11-10 | 2007-05-24 | The University Of North Carolina At Chapel Hill | Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| ES2694726T3 (en) | 2007-06-29 | 2018-12-26 | Sarepta Therapeutics, Inc. | Tissue specific peptide conjugates and methods |
| AU2008273094B2 (en) | 2007-07-12 | 2013-05-09 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| CA2884340C (en) | 2007-11-15 | 2017-07-25 | Sarepta Therapeutics, Inc. | Method of synthesis of morpholino oligomers |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| CN102282155B (en) | 2008-12-02 | 2017-06-09 | 日本波涛生命科学公司 | The synthetic method of the nucleic acid of phosphorus atoms modification |
| PT2417257E (en) | 2009-04-10 | 2016-06-03 | Universität Bern | Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease |
| KR101885383B1 (en) | 2009-07-06 | 2018-08-03 | 웨이브 라이프 사이언시스 리미티드 | Novel nucleic acid prodrugs and methods of use thereof |
| US8470987B2 (en) | 2009-09-16 | 2013-06-25 | Chiralgen, Ltd. | Protective group for synthesis of RNA and derivative |
| WO2012039448A1 (en) | 2010-09-24 | 2012-03-29 | 株式会社キラルジェン | Asymmetric auxiliary group |
| KR102183273B1 (en) | 2011-05-05 | 2020-11-27 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | Peptide Oligonucleotide conjugates |
| PL2581448T3 (en) | 2011-10-13 | 2015-08-31 | Association Inst De Myologie | Tricyclo-phosphorothioate DNA |
| AU2012345638C1 (en) | 2011-11-30 | 2018-10-18 | Sarepta Therapeutics, Inc. | Induced exon inclusion in spinal muscle atrophy |
| NZ627896A (en) | 2012-01-27 | 2016-11-25 | Biomarin Technologies B V | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
| DE102012101676A1 (en) | 2012-02-29 | 2013-08-29 | Klaus-Dieter Rösler | Method and device for processing forms with a data processing system |
| SG10201912895PA (en) | 2012-07-13 | 2020-02-27 | Wave Life Sciences Ltd | Chiral control |
| AU2013288048A1 (en) | 2012-07-13 | 2015-01-22 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
| CN113633787A (en)* | 2013-03-15 | 2021-11-12 | 萨勒普塔医疗公司 | Improved composition for treating muscular dystrophy |
| WO2015108047A1 (en) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator |
| EP3095459A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having antitumor effect and antitumor agent |
| JPWO2015108046A1 (en) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | Chiral nucleic acid adjuvant and antiallergic agent having antiallergic action |
| JP6382344B2 (en) | 2014-01-16 | 2018-08-29 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | Chiral design |
| EP3212793B1 (en) | 2014-11-02 | 2020-01-08 | Arcturus Therapeutics, Inc. | Messenger una molecules and uses thereof |
| MA43072A (en) | 2015-07-22 | 2018-05-30 | Wave Life Sciences Ltd | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES |
| AU2016334232B2 (en) | 2015-10-09 | 2022-05-26 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
| MA45290A (en) | 2016-05-04 | 2019-03-13 | Wave Life Sciences Ltd | PROCESSES AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS |
| MA45270A (en) | 2016-05-04 | 2017-11-09 | Wave Life Sciences Ltd | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES |
| MA45158A (en)* | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | PHARMACEUTICAL COMPOSITION CONSISTING OF ÉTEPLIRSEN |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120289457A1 (en)* | 2011-05-05 | 2012-11-15 | Avi Biopharma, Inc. | Peptide oligonucleotide conjugates |
| WO2017062835A2 (en)* | 2015-10-09 | 2017-04-13 | Sarepta Therapeutics, Inc. | Compositions and methods for treating duchenne muscular dystrophy and related disorders |
| Title |
|---|
| CHARLESTON JAY S. ET AL: "Eteplirsen treatment for Duchenne muscular dystrophy : Exon skipping and dystrophin production", NEUROLOGY, vol. 90, no. 24, 12 June 2018 (2018-06-12), US, pages e2146 - e2154, XP055877433, ISSN: 0028-3878, Retrieved from the Internet <URL:https://n.neurology.org/content/neurology/90/24/e2146.full.pdf> DOI: 10.1212/WNL.0000000000005680* |
| GOEMANS NATHALIE ET AL: "A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy", NEUROMUSCULAR DISORDERS, vol. 28, no. 1, 1 January 2018 (2018-01-01), GB, pages 4 - 15, XP055877283, ISSN: 0960-8966, DOI: 10.1016/j.nmd.2017.10.004* |
| Publication number | Publication date |
|---|---|
| EP4219717A3 (en) | 2023-12-20 |
| EP3806868A2 (en) | 2021-04-21 |
| EP4219717A2 (en) | 2023-08-02 |
| Publication | Publication Date | Title |
|---|---|---|
| EP3821566A4 (en) | DETERMINING A MOST PROBABLE CAUSE FOR TELECOMMUNICATIONS EVENTS | |
| EP3649556A4 (en) | TECHNIQUES FOR SUPPORTING MULTIPLE INTERCONNECTION PROTOCOLS FOR ONE INTERCONNECTION | |
| EP3535032A4 (en) | INSERTION PIVOT CONFIGURATION FOR EXERCISE BIKE | |
| EP3494185A4 (en) | INK SET FOR INK JET | |
| EP3425130C0 (en) | WEAR ELEMENT FOR EARTHWORKING EQUIPMENT | |
| EP3784248A4 (en) | EXON-SKIPPING OLIGOMERS AND OLIGOMER CONJUGATE FOR MUSCLE DYSTROPHY | |
| IL263892A (en) | Exon skipping oligomers for muscular dystrophy | |
| MA52801A (en) | OLIGOMERIC CONJUGATES TO EXON SKIP FOR MUSCLE DYSTROPHY | |
| EP3627918C0 (en) | RADIOSEARCH FOR COVERAGE EXTENSION FOR EC-GSM | |
| EP3862196A4 (en) | TIRE WEAR ESTIMATION PROCEDURE | |
| EP3389462A4 (en) | NON-SLIP DEVICES FOR CLEANING LEARNING | |
| EP3843538C0 (en) | ACCESSORY FOR PETS | |
| EP3874096C0 (en) | WEAR SET | |
| EP3374979A4 (en) | COMMUNICATION CONCENTRATOR FOR INTERVENTION AGENTS | |
| MA52148A (en) | PEPTIDES CHIMÈRES FOR ADMINISTRATION OF ANTISENS | |
| EP3810150A4 (en) | EXON-SKIPPING OLIGOMERS AND OLIGOMER CONJUGATE FOR MUSCLE DYSTROPHY | |
| MA54744A (en) | SELF-LIGATURING BRACKET FOR ORTHODONTICS | |
| EP3806868A4 (en) | EXON-SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | |
| EP3787884A4 (en) | PRE-COMPRESSION SYSTEM FOR PRE-COMPRESSION OF A STRUCTURE | |
| IL280299A (en) | Exon-skipping oligomers for muscular dystrophy | |
| EP3617398A4 (en) | CORD FOR REINFORCING ELASTOMERS | |
| FR3046235B1 (en) | INTERCHANGEABLE SUPPORT FOR FASTENING A TURBOMACHINE | |
| FR3033489B3 (en) | GUIDE FOR THE POSITIONING OF ORTHODONTIC ATTACHES | |
| EP3950571A4 (en) | ACCESSORY FOR PET BOTTLE | |
| EP3658023C0 (en) | PROCESS FOR ASSESSING BALANCE |
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE | |
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: REQUEST FOR EXAMINATION WAS MADE | |
| 17P | Request for examination filed | Effective date:20210106 | |
| AK | Designated contracting states | Kind code of ref document:A2 Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | |
| AX | Request for extension of the european patent | Extension state:BA ME | |
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61P 21/00 20060101ALI20220216BHEP Ipc:A61K 31/7125 20060101ALI20220216BHEP Ipc:A61K 31/7088 20060101ALI20220216BHEP Ipc:C12N 15/113 20100101AFI20220216BHEP | |
| REG | Reference to a national code | Ref country code:DE Ref legal event code:R079 Free format text:PREVIOUS MAIN CLASS: A61K0031708800 Ipc:C12N0015113000 | |
| A4 | Supplementary search report drawn up and despatched | Effective date:20220525 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61P 21/00 20060101ALI20220519BHEP Ipc:A61K 31/7125 20060101ALI20220519BHEP Ipc:A61K 31/7088 20060101ALI20220519BHEP Ipc:C12N 15/113 20100101AFI20220519BHEP | |
| RIN1 | Information on inventor provided before grant (corrected) | Inventor name:BESTWICK, RICHARD Inventor name:ZHOU, MING Inventor name:HANSON, GUNNAR Inventor name:ESTRELLA, NELSA Inventor name:PASSINI, MARCO Inventor name:SCHNELL, FREDERICK, JOSEPH | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:20230103 |